HVC
ZGNX

Healthcare Value Capital’s Zogenix, Inc. ZGNX Stock Holding History

Healthcare Value Capital’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,850
Closed -$346K – 23
2017
Q1 		$346K Hold
31,850
– – 0.59% 17
2016
Q4 		$387K Hold
31,850
– – 0.41% 19
2016
Q3 		$364K Hold
31,850
– – 0.58% 18
2016
Q2 		$256K Hold
31,850
– – 0.31% 21
2016
Q1 		$294K Hold
31,850
– – 0.43% 26
2015
Q4 		$469K Hold
31,850
– – 0.78% 17
2015
Q3 		$430K Buy
31,850
+600
+2% +$10.8K 0.61% 22
2015
Q2 		$420K Sell
31,250
-31,250
-50% -$383K 0.44% 28
2015
Q1 		$685K Buy
+62,500
New +$707K 0.75% 24
2014
Q4 		– Sell
-18,750
Closed -$173K – 40
2014
Q3 		$173K Sell
18,750
-12,500
-40% -$142K 0.17% 32
2014
Q2 		$503K Buy
31,250
+18,750
+150% +$339K 0.42% 26
2014
Q1 		$285K Sell
12,500
-9,542
-43% -$311K 0.19% 45
2013
Q4 		$607K Sell
22,042
-12,500
-36% -$280K 0.45% 28
2013
Q3 		$511K Hold
34,542
– – 0.45% 41
2013
Q2 		$473K Buy
+34,542
New +$442K 0.34% 51

Other funds holding ZGNX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Healthcare Value Capital's ZGNX Position: Q2 2017 in Review

Healthcare Value Capital sold out of Zogenix, Inc. (ZGNX) in Q2 2017, closing a stake of 31,850 shares — an estimated $346K sold.

Healthcare Value Capital first reported a position in ZGNX in Q2 2013 and held it in 15 quarters. The position peaked at $685K in Q1 2015. 92 funds tracked by Wall St. Rank hold ZGNX as of Q2 2017.

  • Healthcare Value Capital reported no remaining Zogenix, Inc. position as of Q2 2017 after selling out during the quarter.
  • Healthcare Value Capital sold 31,850 Zogenix, Inc. shares in Q2 2017, an estimated $346K.
  • Healthcare Value Capital first reported a position in Zogenix, Inc. in Q2 2013 and held it in 15 quarters.
  • Healthcare Value Capital's Zogenix, Inc. position peaked at $685K in Q1 2015.
  • 92 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q2 2017.

Based on Healthcare Value Capital's 13F filing for Q2 2017, filed 10 Aug 2017.